Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Whole Genome Microarray comparison of two Interferon Beta 1a Pharmaceutical Preparations

ABSTRACT: We have investigated the in vitro pharmacodynamic genomic effects of interferon beta 1a treatment on a whole genome microarray assay on lymphocytes from Multiple Sclerosis patients comparing the similarity between two biological products manufactured by two pharmaceutical companies. Keywords: Drug pharmacogenomics

ORGANISM(S): Homo sapiens

PROVIDER: GSE6692 | GEO | 2008/06/30

SECONDARY ACCESSION(S): PRJNA99075

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Pharmaceutical sludge

Project description:Pharmaceutical sludge Metagenome

| PRJNA509337 | ENA

Expression data of multiple sclerosis patients receiving intramuscular Interferon-beta-1a therapy [U133 A and B]

Project description:The purpose of this study was to characterize the transcriptional effects induced by intramuscular IFN-beta-1a treatment (Avonex, 30 µg once weekly) in patients with relapsing-remitting form of multiple sclerosis (MS). By using Affymetrix DNA microarrays, we obtained genome-wide expression profiles of peripheral blood mononuclear cells from 24 MS patients within the first four weeks of IFN-beta administration. Keywords: Multiple sclerosis, Interferon, Pharmacogenomics, Affymetrix

2009-12-03 | GSE19285 | GEO

Enterococcus mundtii 1A strain:1A

Project description:Enterococcus mundtii 1A strain:1A Genome sequencing

| PRJNA172933 | ENA

Escherichia coli 1A strain:1A

Project description:Escherichia coli 1A strain:1A Genome sequencing and assembly

| PRJNA224231 | ENA

Pharmaceutical degrading enrichment cultures

Project description:Pharmaceutical degrading enrichment cultures Raw sequence reads

| PRJNA782474 | ENA

Activated sludge from Pharmaceutical industry

Project description:Activated sludge from Pharmaceutical industry Metagenome

| PRJNA509309 | ENA

Saccharomyces cerevisiae cells: W303-1A vs W303-1A delta MSN2, MSN4

2008-12-23 | GSE11878 | GEO

Saccharomyces cerevisiae cells: W303-1A vs W303-1A delta MSN2, MSN4

Project description:Transcriptional profiling of Saccharomyces cerevisiae cells comparing the W303-1A wildtype with the W303-1A double mutant for MSN2 and MSN4 during zinc deficient conditions Keywords: Genetic modification with zinc limitation Two condition experiment, W303-1A vs W303-1A delta MSN2, MSN4. Biological replicates: 2 wildtype, 2 knock-out, independently grown and harvested.

2008-12-22 | E-GEOD-11878 | biostudies-arrayexpress

Pyrolobus fumarii 1A strain:1A

Project description:Pyrolobus fumarii 1A whole genome sequencing project.

| PRJNA48579 | ENA

PGC-1a overexpression in SH-SY5Y cells

Project description:SH-SY5Y cells were transfected with either GFP control or PGC-1a overexpression adenovirus and RNA was isolated after 48 hours and sequenced in order to understand what genes are differentially expressed with the presence of PGC-1a in neuron like cells. This experiment shows that genes related to neuron health and mitochondiral function are controlled by PGC-1a. We also analyze the promoter of upregualted genes found here to figure out potential partners that co-regulate with PGC-1a.

2021-05-31 | GSE151499 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data